BACKGROUND: @entity299 is an important cause of long-term graft loss. In adults, percutaneous revascularization procedures (PRPs) have variable success with high restenosis rates and little impact on graft survival. Limited data exist in pediatric recipients of transplants. METHODS: Data from the Pediatric Heart Transplant Study (PHTS) were used to explore associations between PRPs and outcomes after heart transplant in @entity1 listed  <=18 years old who received a first heart transplant between 1993 and 2009. RESULTS: Revascularization procedures were done in 28 of 3,156 (0.9%) @entity1 ; 13 @entity1 had multiple PRPs giving a total of 51 PRPs performed across 15 centers. Mean recipient age at time of transplant was 7.7    6.7 years; mean donor age was 15.9    15.4 years. The mean time to first PRP was 5.7    3.2 years. Vessels involved were left anterior descending artery (41%), right coronary artery (25%), circumflex artery (18%), other coronary branches/unknown (16%). PRPs consisted of 38 (75%) stent implantations and 13 (25%) balloon angioplasties with an overall procedural success rate of 73%. Freedom from graft loss after PRPs was 89%, 75%, and 61% at 1, 3, and 12 months. In addition, @entity1 with transplants from donors >30 years old were found to have less freedom from the need for a revascularization procedure than @entity1 with transplants from younger donors (p < 0.0001). CONCLUSIONS: In this large pediatric heart transplant cohort, use of PRPs for @entity299 was rare, likely related to procedural feasibility of the interventions. Despite technically successful interventions, graft loss occurred in 39% within 1 year post-procedure; relisting for heart transplant should be considered.

Outcomes after percutaneous coronary artery revascularization procedures for XXXX in pediatric heart transplant recipients: A multi-institutional study.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity299 :: ('MESH:D006331', 'Disease') :: ['cardiac allograft vasculopathy', 'Cardiac allograft vasculopathy']
@entity299 :: (MESH:D006331,Disease) :: ['cardiac allograft vasculopathy']
